Connect with us
VB Devices closed 2021 with sales of $339,000 (€315,000), the target for 2022 is to achieve $977,000 (€909,000) and for 2023 to exceed $1.6 million (€1.5...
Diets are like the financial equivalent of credit cards and get-rich-quick schemes. At best, they do nothing to fix your short-term problems. At worst, they do...
The company maintains its growth forecasts. By 2022, Moonz expects to earn just over eight million euros, which would double the figure for the year of...
Minoryx Therapeutics, based in Mataró (Barcelona), will also finance the activities necessary to be able to proceed with the approval of leriglitazone in the United States...
Leo Pharma recorded a turnover of $1.44 billion (€1.34 billion) in 2021. The company has a strategic focus on drugs for skin diseases such as atopic...
Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
Of the total amount that Laminar Pharma estimates it needs, $10.7 million (€10 million) correspond to bank financing already agreed with Banca March. In addition, the...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...
Indac's new fund, Indaco Bio is focused on Italy, but will not lack significant room for investments abroad, particularly in Europe, North America, and Israel. The...
There are currently five million people with spinal cord injuries worldwide and this figure is increasing with half a million more people every year, according to...
 |
|
 |  |
 |
|